HDA 2025 Traceability Seminar

In a presentation titled “The Next Phase of DSCSA Traceability,” Abha will address the cessation of key exemption periods for enhanced drug distribution security requirements under the Drug Supply Chain Security Act (DSCSA). As a former leader of the Food and Drug Administration’s DSCSA implementation and compliance program, Abha will use her firsthand perspective to offer valuable insights into what stakeholders can expect as the industry transitions into the next phase of traceability.

HDA’s 2025 Traceability Seminar convenes pharmaceutical distributors, pharmacies, and supply chain practitioners with responsibility over implementation of traceability strategy, systems, and processes to learn more about DSCSA implementation milestones and share strategies for preserving the safety and security of the health care supply chain.